Professional
Added to YB: 2025-01-20
Pitch date: 2024-12-31
MEDP [bullish]
Medpace Holdings, Inc.
+28.42%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
N/A
Pitch Price
$334.92
Price Target
N/A
Dividend
N/A
EV/EBITDA
18.14
P/E
26.45
EV/Sales
N/A
Sector
Life Sciences Tools and Services
Category
growth
Vulcan Value Partners All Cap Review New Position: Medpace Holdings, Inc.
MEDP: Top 10 global CRO for drug development. Full-service model attracts small/mid biotech. Less price-sensitive clients. Double-digit revenue/profit growth. Strong FCF, balance sheet & capital allocation. End-to-end services for less price-sensitive small/mid biotech clients.
Read full article (1 min)